The Latest Cardiac and Vascular News
Incidental CAC Scores Now Possible with ClearRead™ CT MIAMISBURG, Ohio, Dec. 3, 2024 /PRNewswire/ — Coronary artery calcification (CAC) affects 20 million Americans annually, and over half of the incidental findings go unreported.* New FDA-cleared technology from Riverain can provide a…
December 3, 2024
First Time in the Company’s History REDWOOD CITY, Calif., Dec. 3, 2024 /PRNewswire/ — Biotricity Inc. (OTCQB: BTCY) (“Biotricity” or the “Company”), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced achieving…
BTL, a leader in medical innovation, is proud to announce a major milestone: the successful treatment of the first patients suffering from atrial fibrillation (AF) in a groundbreaking study using a next-generation catheter designed to improve the way AF is treated. PRAGUE, Dec. 3, 2024…
KOLKATA, India, Dec. 3, 2024 /PRNewswire/ — Marking a transformative milestone in cardiac care, Manipal Hospitals, one of the largest healthcare networks in India announced the successful insertion of an AI-driven, wireless injectable pacemaker. The Aveir Leadless pacemaker by Abbott,…
IRVINE, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced it has entered into a joint venture with 6 Dimensions Capital (“6 Dimensions”) and its successor fund 120 Capital, and VFLO Medical (“VFLO”), a medical device platform incubated by 6 Dimensions and 120 Capital, to provide access to Inari’s innovative technology for patients with significant unmet needs in Greater China.
Mindray Sets a New Standard with its Resona-Series Ultrasound Machines and Upcoming Expansion into Digital Radiography MAHWAH, N.J., Dec. 2, 2024 /PRNewswire/ — Mindray, a leading global developer of healthcare technologies and solutions specializing in patient monitoring, anesthesia,…
COLUMBUS, Ohio, Dec. 2, 2024 /PRNewswire/ — Royal Health Inc., the leader in cloud-native radiology workflow and patient experience solutions, has been selected by LucidHealth to support its multi-state outpatient imaging center operations with a seamless, single-vendor platform for…
COPENHAGEN, Denmark, Dec. 2, 2024 /PRNewswire/ — CathVision, an electrophysiology (EP) solution innovator, is proud to unveil the latest ECGenius System update. This release brings essential enhancements to streamline workflows and boost procedural efficiency in EP labs. Notably, the EMR…
SILVER SPRING, Md., Dec. 02, 2024 (GLOBE NEWSWIRE) — Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, announced it has been awarded a national group purchasing agreement for Cardiac Rhythm Management Devices with Premier, Inc. Effective November 15, 2024, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for the EluPro™ Antibiotic-Eluting BioEnvelope.
